AQST Stock Analysis

Aquestive Therapeutics Inc (AQST): A Detailed Educational Stock Research Review

Overview of Aquestive Therapeutics Inc (AQST)

Aquestive Therapeutics Inc (AQST) is a specialty pharmaceutical company operating in the healthcare sector, specifically within the drug manufacturers - specialty and generic industry. The company focuses on developing and commercializing differentiated products to address unmet medical needs. As an educational review from StockValueFinder.com, this article examines AQST using a structured, number-driven approach to help investors understand how to evaluate stocks based on fundamental and valuation metrics.

At the time of this review, AQST trades at $4.23 per share. The StockValueFinder score for AQST is 43%, resulting in an "AVOID" rating. This score reflects a combination of financial health, profitability, valuation, and trend metrics. While no single metric determines a stock's quality, the overall score provides a disciplined framework for assessing investment potential.

This review will walk through each key metric used in the StockValueFinder system, explaining what the numbers mean, why they matter, and how AQST performs against established benchmarks. The goal is to help readers learn how to evaluate stocks systematically, not to make specific buy or sell recommendations.

Why the StockValueFinder Score Matters

The StockValueFinder score is a composite measure designed to reflect a company's financial strength, profitability, valuation, and market trend. Scores range from 0% to 100%, with higher scores indicating stronger overall fundamentals. The rating system is as follows:

AQST's score of 43% places it in the "AVOID" category. This rating suggests that the company exhibits significant financial or operational weaknesses that may pose risks for investors. However, it's important to note that an "AVOID" rating does not mean the stock will necessarily decline—it simply indicates that the current financial profile does not meet the system's criteria for a higher-quality investment.

Scores are based on a combination of quantitative metrics, including earnings consistency, return on invested capital (ROIC), interest coverage, debt payback, price-to-earnings (P/E) ratio, and moving average trends. Each metric is assigned a pass or fail based on predefined benchmarks, and the overall score reflects the proportion of tests passed.

EPS Strength and Consistency

What Is EPS and Why Does It Matter?

Earnings per share (EPS) measures a company's profitability on a per-share basis. It is calculated by dividing net income by the number of outstanding shares. EPS consistency is important because it reflects a company's ability to generate stable or growing profits over time. Investors generally prefer companies with predictable earnings, as this reduces uncertainty and suggests a more reliable business model.

StockValueFinder EPS Benchmarks

StockValueFinder evaluates EPS strength based on

A strong EPS profile typically includes

A weak EPS profile may include

AQST EPS Performance

The StockValueFinder system recorded a **fail** for AQST's EPS test. While exact EPS values for recent quarters or years are not supplied, the fail result indicates that the company does not meet the system's criteria for earnings consistency or positivity.

For example, if a company like Johnson & Johnson (JNJ) reports EPS of $2.50, $2.60, and $2.70 over three consecutive years, it demonstrates consistent growth and would likely pass the EPS test. In contrast, a company with EPS of -$0.50, $0.20, and -$0.30 would fail due to volatility and negative earnings.

Investors should note that early-stage pharmaceutical companies often report negative EPS as they invest heavily in research and development (R&D). However, the StockValueFinder system prioritizes profitability and consistency, which may disadvantage companies in high-growth but unprofitable industries.

ROIC and Capital Efficiency

What Is ROIC and Why Does It Matter?

Return on invested capital (ROIC) measures how effectively a company uses its capital to generate profits. It is calculated as:

**ROIC = (Net Operating Profit After Taxes) / (Total Invested Capital)**

ROIC is a critical metric because it reveals whether a company is generating sufficient returns on the money it invests in its business. Companies with high ROIC are often more efficient and have stronger competitive advantages, such as patents, brand recognition, or cost leadership.

StockValueFinder ROIC Benchmarks

StockValueFinder generally prefers companies with

A weak ROIC profile may include

AQST ROIC Performance

AQST's ROIC is **-85.68%**, which is deeply negative. This means the company is not generating a positive return on the capital it has invested in its operations. In fact, it is losing money on its investments at a significant rate.

For context, consider two hypothetical companies

AQST's ROIC of -85.68% is far worse than Company B, suggesting that the company is currently destroying value rather than creating it. This is a red flag for investors, as it indicates that the company's business model or operations may not be sustainable without significant improvements.

The StockValueFinder system recorded a **fail** for AQST's ROIC test, reflecting the company's poor capital efficiency.

Interest Coverage and Financial Safety

What Is Interest Coverage and Why Does It Matter?

Interest coverage measures a company's ability to pay the interest on its debt. It is calculated as:

**Interest Coverage = (Earnings Before Interest and Taxes) / (Interest Expense)**

A higher interest coverage ratio indicates that a company can comfortably service its debt, while a lower ratio suggests financial strain. Companies with weak interest coverage may struggle to meet their debt obligations, increasing the risk of default or bankruptcy.

StockValueFinder Interest Coverage Benchmarks

StockValueFinder prefers companies with

A weak interest coverage profile may include

AQST Interest Coverage Performance

The StockValueFinder system recorded a **fail** for AQST's interest coverage test. While the exact interest coverage ratio is not supplied, the fail result indicates that the company does not meet the system's benchmark of 6 or higher.

For example

AQST's failure of this test suggests that the company may be struggling to generate sufficient earnings to cover its debt obligations, which is a significant risk factor for investors.

Debt Payback and Balance Sheet Discipline

What Is Debt Payback and Why Does It Matter?

Debt payback measures how long it would take a company to pay off its total debt using its current operating cash flow. It is calculated as:

**Debt Payback (Years) = (Total Debt) / (Operating Cash Flow)**

A shorter debt payback period indicates a stronger balance sheet and lower financial risk. Companies with long debt payback periods may struggle to manage their debt load, especially in economic downturns or periods of rising interest rates.

StockValueFinder Debt Payback Benchmarks

StockValueFinder prefers companies with

A weak debt payback profile may include

AQST Debt Payback Performance

AQST's debt payback is **-0.52 years**. While this number is negative, the StockValueFinder system recorded a **pass** for this test. This may seem counterintuitive, but it reflects the system's interpretation of negative debt payback in certain contexts.

A negative debt payback typically occurs when a company has negative operating cash flow, meaning it is not generating enough cash from its operations to cover its debt. However, in some cases, early-stage or high-growth companies may have negative operating cash flow due to heavy investment in R&D or expansion, even if they have manageable debt levels.

For example

While AQST passed this test, investors should interpret the negative debt payback with caution. It suggests that the company is not generating positive operating cash flow, which could pose risks if the company cannot secure additional financing or improve its cash flow generation.

P/E Ratio and Valuation Discipline

What Is P/E Ratio and Why Does It Matter?

The price-to-earnings (P/E) ratio measures a company's stock price relative to its earnings per share. It is calculated as:

**P/E Ratio = (Stock Price) / (Earnings Per Share)**

The P/E ratio is a key valuation metric because it helps investors assess whether a stock is overvalued or undervalued relative to its earnings. A lower P/E ratio may indicate a more attractively priced stock, while a higher P/E ratio may suggest overvaluation.

StockValueFinder P/E Ratio Benchmarks

StockValueFinder prefers companies with

A weak P/E profile may include

AQST P/E Ratio Performance

AQST's P/E ratio is **-5.72**, which is negative. The StockValueFinder system recorded a **pass** for this test, but this requires careful interpretation.

A negative P/E ratio occurs when a company reports negative earnings, meaning it is not profitable. In such cases, the P/E ratio cannot be used to assess valuation in the traditional sense, as there are no earnings to compare to the stock price. However, the StockValueFinder system may pass companies with negative P/E ratios if other metrics (such as debt payback or trend) suggest potential for future profitability.

For example

While AQST passed the P/E test, investors should note that the negative P/E ratio reflects the company's lack of profitability. This is a significant risk factor, as unprofitable companies may struggle to sustain operations without external financing or a turnaround in earnings.

Moving Average Trend and Entry Timing

What Is the Moving Average Trend and Why Does It Matter?

The moving average trend is a technical indicator that helps investors assess the stock's price momentum. It is calculated by comparing the stock's current price to its moving averages (e.g., 50-day or 200-day moving averages). A stock trading above its moving averages may be in an uptrend, while a stock trading below its moving averages may be in a downtrend.

Moving averages are used for timing discipline, not as proof that a stock will rise or fall. They help investors avoid buying stocks in clear downtrends or selling stocks in clear uptrends.

StockValueFinder Moving Average Benchmarks

StockValueFinder evaluates moving averages based on

AQST Moving Average Performance

AQST's moving average signal is **NEUTRAL / WATCH**, and the entry signal is **N/A**. This indicates that the stock is not in a clear uptrend or downtrend based on its moving averages.

For example

AQST's neutral signal suggests that the stock is not exhibiting strong momentum in either direction. This is neither a positive nor a negative signal on its own, but it does indicate that the stock may lack clear directional conviction.

Overall Financial Strengths and Weaknesses

Strengths

1. **Passed the Debt Payback Test**: While AQST's debt payback is negative, the system passed this test, suggesting that the company's debt levels may not be an immediate concern relative to its cash flow profile. 2. **Passed the P/E Valuation Test**: The negative P/E ratio is not ideal, but the system passed this test, indicating that the stock is not overvalued based on traditional metrics.

Weaknesses

1. **Failed the EPS Test**: AQST does not meet the system's criteria for earnings consistency or positivity, reflecting its lack of profitability. 2. **Failed the ROIC Test**: With an ROIC of -85.68%, the company is destroying value with its investments, indicating poor capital efficiency. 3. **Failed the Interest Coverage Test**: The company does not meet the system's benchmark for interest coverage, suggesting financial strain and higher risk of default. 4. **Neutral Moving Average Trend**: The stock lacks clear momentum, which may make it less attractive for trend-following investors.

Risks and Limitations

Investing in AQST carries several risks and limitations that investors should consider

1. **Lack of Profitability**: AQST's negative EPS and ROIC indicate that the company is not currently profitable and is destroying value with its investments. This is a significant risk, as unprofitable companies may struggle to sustain operations without external financing or a turnaround in earnings.

2. **Financial Strain**: The company's failure of the interest coverage test suggests that it may be struggling to meet its debt obligations. This increases the risk of default or bankruptcy, especially in a rising interest rate environment.

3. **Negative Operating Cash Flow**: AQST's negative debt payback reflects negative operating cash flow, meaning the company is not generating enough cash from its operations to cover its debt. This is a red flag for long-term sustainability.

4. **Industry-Specific Risks**: As a specialty pharmaceutical company, AQST faces risks related to drug development, regulatory approvals, patent expirations, and competition. These risks are inherent to the industry and may impact the company's ability to achieve profitability.

5. **Market Volatility**: AQST's neutral moving average trend suggests that the stock lacks clear momentum. This may result in higher volatility and less predictable price movements.

6. **Limited Valuation Insight**: AQST's negative P/E ratio means that traditional valuation metrics cannot be applied. Investors must rely on other factors, such as cash flow projections or industry comparisons, to assess the stock's value.

Educational Conclusion

This review of Aquestive Therapeutics Inc (AQST) provides a structured, number-driven approach to evaluating stocks. By examining key metrics such as EPS, ROIC, interest coverage, debt payback, P/E ratio, and moving average trends, investors can gain a clearer understanding of a company's financial health and investment potential.

AQST's StockValueFinder score of 43% and "AVOID" rating reflect significant weaknesses in profitability, capital efficiency, and financial safety. While the company passed the debt payback and P/E valuation tests, its negative ROIC, failed EPS and interest coverage tests, and neutral moving average trend suggest that it may not meet the criteria for a high-quality investment under the StockValueFinder system.

For educational purposes, this review highlights the importance of

1. **Earnings Consistency**: Companies with stable or growing EPS are generally less risky and more reliable. 2. **Capital Efficiency**: High ROIC indicates that a company is using its capital effectively to generate profits. 3. **Financial Safety**: Strong interest coverage and manageable debt payback periods reduce the risk of default. 4. **Valuation Discipline**: A reasonable P/E ratio helps ensure that investors are not overpaying for a stock. 5. **Trend Awareness**: Moving averages provide insight into a stock's momentum and can help with timing decisions.

Investors should use this framework to evaluate other stocks, always considering their own risk tolerance, investment goals, and time horizon. No single metric or system can guarantee success, and all investments carry some level of risk.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.

Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings